GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
- PMID: 35838905
- DOI: 10.1245/s10434-022-12151-6
GLOBOCAN 2020 Report on Global Cancer Burden: Challenges and Opportunities for Surgical Oncologists
Abstract
Cancer is emerging as a major public health challenge globally. Recently, IARC (International Association of Research on Cancer) published global cancer burden using GLOBOCAN 2020 estimates for 36 cancers in 185 countries of the world. As per the estimates of the World Health Organization (WHO) in 2019, cancer is the first or second leading cause of death in 112 of 183 countries. The major takeaways of the GLOBOCAN 2020 report relevant to the surgical oncology community include the rising global burden of cancer, global disparity in cancer incidence and mortality in different geographic regions, and the impact of the human development index (HDI) on cancer incidence and projected global cancer burden by 2040. In this article, we discuss the implications of the GLOBOCAN report on future global cancer control strategies and the role of surgical oncologists in the fight against cancer.
© 2022. Society of Surgical Oncology.
Similar articles
-
Variations in Training of Surgical Oncologists: Proposal for a Global Curriculum.Ann Surg Oncol. 2016 Jun;23(6):1769-81. doi: 10.1245/s10434-016-5238-8. Epub 2016 Apr 27. Ann Surg Oncol. 2016. PMID: 27120186
-
Global Curriculum in Surgical Oncology.Ann Surg Oncol. 2016 Jun;23(6):1782-95. doi: 10.1245/s10434-016-5239-7. Epub 2016 Apr 27. Ann Surg Oncol. 2016. PMID: 27120187
-
Variations in training of surgical oncologists: Proposal for a global curriculum.Eur J Surg Oncol. 2016 Jun;42(6):767-78. doi: 10.1016/j.ejso.2016.04.004. Epub 2016 May 5. Eur J Surg Oncol. 2016. PMID: 27156146
-
The training and certification of surgical oncologists globally.Ann Surg Oncol. 2015 Mar;22(3):710-8. doi: 10.1245/s10434-014-4343-9. Epub 2015 Jan 21. Ann Surg Oncol. 2015. PMID: 25605512 Review.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database.Heliyon. 2024 Sep 5;10(18):e37348. doi: 10.1016/j.heliyon.2024.e37348. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309940 Free PMC article.
-
Preparation and investigation of a novel combination of Solanum nigrum-loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: in vitro, in vivo, and in silico evaluation.Front Pharmacol. 2023 Dec 6;14:1325498. doi: 10.3389/fphar.2023.1325498. eCollection 2023. Front Pharmacol. 2023. PMID: 38125886 Free PMC article.
-
SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis.Aging (Albany NY). 2023 Aug 10;15(15):7451-7475. doi: 10.18632/aging.204911. Epub 2023 Aug 10. Aging (Albany NY). 2023. PMID: 37566748 Free PMC article.
-
Treatment and mortality risk of older adults with non-small cell cancer in Taiwan: A population-based cohort study.Thorac Cancer. 2023 Sep;14(26):2687-2695. doi: 10.1111/1759-7714.15055. Epub 2023 Aug 8. Thorac Cancer. 2023. PMID: 37551918 Free PMC article.
-
Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.Breast Cancer Res. 2024 Mar 29;26(1):54. doi: 10.1186/s13058-024-01808-7. Breast Cancer Res. 2024. PMID: 38553760 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - DOI
-
- Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. - DOI
-
- D’Cruz AK, Vaish R. Risk-based oral cancer screening—lessons to be learnt. Nat Rev Clin Oncol. 2021;18:471–2. - DOI
-
- Zhang X, Zeng Q, Cai W, Ruan W. Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019. BMC Public Health. 2021;21:894–904. - DOI
-
- Mittra I, Mishra GA, Dikshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: a prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;24(372):n256. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials